Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
8 papers
Recent·Most cited
L. Matha, L. Krabbendam, S. Martinez-Hoyer…·I. Martinez-Gonzalez
This study identifies CD127-negative ILC2s with immunological memory features in both healthy and inflamed tissues.
L. Hanke, D. J. Sheward, A. Pankow…·B. Murrell
This study identifies potent cross-neutralizing SARS-CoV-2 nanobodies from an alpaca immune repertoire using phage display and epitope mapping.
C. H. Classon, M. Li, J. Ma…·S. Nylen
This study shows that intestinal helminth infection alters CD4+ T cell composition in the skin, leading to long-term changes in immune responses to antigens.
D. J. Sheward, M. Mandolesi, E. Urgard…·B. Murrell
A single dose of a VOC-derived RBD protein boost enhances potent neutralizing antibodies against both Wu-Hu-1 and the VOC in previously vaccinated rhesus macaques.
J. Ma, C. H. Classon, J. M. Stark…·J. M. Coquet
The paper shows that mice with a diverse wild microbiota develop stronger allergic inflammation compared to those without microbial exposure.
L. Hanke, H. Das, D. Sheward…·G. M. McInerney
A bispecific nanobody neutralizes SARS-CoV-2 and its variant B.1.351 by inducing spike trimer-dimers that prevent ACE2 binding.
J. M. Stark, J. Liu, C. A. Tibbitt…·J. M. Coquet
This study shows that sublingual immunotherapy with recombinant dog allergens reduces airway hyperresponsiveness and type 2 inflammation in a mouse model of dog allergy.
M. Mandolesi, D. J. Sheward, L. Hanke…·B. Murrell
This study shows that SARS-CoV-2 spike protein subunit vaccines induce strong neutralizing antibodies in mice and macaques, with high titers after a single dose or dose-sparing regimen.